{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:15:17Z","timestamp":1795040117394,"version":"4.10.2"},"reference-count":41,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.brainres.2013.11.028","type":"journal-article","created":{"date-parts":[[2013,12,7]],"date-time":"2013-12-07T11:15:34Z","timestamp":1386414934000},"page":"33-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Combined treatment with acupuncture reduces effective dose and alleviates adverse effect of l-dopa by normalizing Parkinson's disease-induced neurochemical imbalance"],"prefix":"10.1016","volume":"1544","author":[{"given":"Seung-Nam","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ah-Reum","family":"Doo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yeun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunwoo J.","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insop","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongbae J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younbyoung","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bena","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyejung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hi-Joon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2013.11.028_bib1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/nbdi.1999.0259","article-title":"Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease","volume":"6","author":"Andersson","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2013.11.028_bib2","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S1474-4422(09)70225-X","article-title":"A reassessment of risks and benefits of dopamine agonists in Parkinson's disease","volume":"8","author":"Antonini","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2013.11.028_bib3","doi-asserted-by":"crossref","first-page":"12513","DOI":"10.1523\/JNEUROSCI.2236-11.2011","article-title":"Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease","volume":"31","author":"Bagetta","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2013.11.028_bib4","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1471-4159.2011.07376.x","article-title":"Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels","volume":"118","author":"Bido","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2013.11.028_bib5","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"BJ","year":"2008"},{"key":"10.1016\/j.brainres.2013.11.028_bib6","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S1474-4422(10)70218-0","article-title":"Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap","volume":"9","author":"Calabresi","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2013.11.028_bib7","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1523\/JNEUROSCI.0252-10.2010","article-title":"Striatal overexpression of DeltaFosB reproduces chronic levodopa-induced involuntary movements","volume":"30","author":"Cao","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2013.11.028_bib8","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1212\/WNL.41.5.622","article-title":"\"Early\" initiation of levodopa treatment does not promote the development of motor response fluctuations, dyskinesias, or dementia in Parkinson's disease","volume":"41","author":"Cedarbaum","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2013.11.028_bib9","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1046\/j.1460-9568.1998.00285.x","article-title":"l-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA","volume":"10","author":"Cenci","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2013.11.028_bib10","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/mds.22673","article-title":"Parsing brain activity associated with acupuncture treatment in Parkinson's diseases","volume":"24","author":"Chae","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainres.2013.11.028_bib11","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.parkreldis.2012.04.030","article-title":"Effectiveness of acupuncture and bee venom acupuncture in idiopathic Parkinson's disease","volume":"18","author":"Cho","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.brainres.2013.11.028_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fnana.2011.00059","article-title":"Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments","volume":"5","author":"Crittenden","year":"2011","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.brainres.2013.11.028_bib13","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1073\/pnas.1006511108","article-title":"Enhanced striatal cholinergic neuronal activity mediates l-DOPA-induced dyskinesia in parkinsonian mice","volume":"108","author":"Ding","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2013.11.028_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb07458.x","article-title":"Description of Parkinson's disease as a clinical syndrome","volume":"991","author":"Fahn","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.brainres.2013.11.028_bib15","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1056\/NEJMoa033447","article-title":"Levodopa and the progression of Parkinson's disease","volume":"351","author":"Fahn","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2013.11.028_bib16","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/pmj.78.924.612","article-title":"Use of complementary therapies and non-prescribed medication in patients with Parkinson's disease","volume":"78","author":"Ferry","year":"2002","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.brainres.2013.11.028_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fnbeh.2011.00071","article-title":"l-DOPA-Induced dyskinesia and abnormal signaling in striatal medium spiny neurons: focus on dopamine D1 receptor-mediated transmission","volume":"5","author":"Feyder","year":"2011","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.brainres.2013.11.028_bib18","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nature04172","article-title":"Morphine reward in dopamine-deficient mice","volume":"438","author":"Hnasko","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2013.11.028_bib19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/00207450903316527","article-title":"Complementary acupuncture in Parkinson's disease: a spect study","volume":"120","author":"Huang","year":"2010","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.brainres.2013.11.028_bib20","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1002\/pmic.200700955","article-title":"Proteomic analysis of the neuroprotective mechanisms of acupuncture treatment in a Parkinson's disease mouse model","volume":"8","author":"Jeon","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.brainres.2013.11.028_bib21","doi-asserted-by":"crossref","first-page":"e27566","DOI":"10.1371\/journal.pone.0027566","article-title":"Acupuncture enhances the synaptic dopamine availability to improve motor function in a mouse model of Parkinson's disease","volume":"6","author":"Kim","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2013.11.028_bib22","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3109\/00207454.2011.591515","article-title":"Phosphatidylinositol 3-kinase\/Akt signaling pathway mediates acupuncture-induced dopaminergic neuron protection and motor function improvement in a mouse model of Parkinson's disease","volume":"121","author":"Kim","year":"2011","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.brainres.2013.11.028_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12576-009-0061-7","article-title":"The effect of electroaucpuncture for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced proteomic changes in the mouse striatum","volume":"60","author":"Kim","year":"2010","journal-title":"J. Physiol. Sci."},{"key":"10.1016\/j.brainres.2013.11.028_bib24","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.neuropharm.2009.01.019","article-title":"Evaluation of D2 and D3 dopamine receptor selective compounds on l-dopa-dependent abnormal involuntary movements in rats","volume":"56","author":"Kumar","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2013.11.028_bib25","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1212\/01.WNL.0000152880.77812.5B","article-title":"\"Levodopa phobia\": a new iatrogenic cause of disability in Parkinson disease","volume":"64","author":"Kurlan","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2013.11.028_bib26","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1126\/science.1184334","article-title":"Channel-mediated tonic GABA release from glia","volume":"330","author":"Lee","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.brainres.2013.11.028_bib27","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.expneurol.2010.07.018","article-title":"Deuterium substitutions in the l-DOPA molecule improve its anti-akinetic potency without increasing dyskinesias","volume":"225","author":"Malmlof","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2013.11.028_bib28","doi-asserted-by":"crossref","first-page":"16106","DOI":"10.1523\/JNEUROSCI.6408-11.2012","article-title":"Nociceptin\/orphanin FQ receptor agonists attenuate l-DOPA-induced dyskinesias","volume":"32","author":"Marti","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2013.11.028_bib29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.nbd.2011.09.015","article-title":"In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to l-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels","volume":"45","author":"Mela","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2013.11.028_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2009.08.009","article-title":"An fMRI study of neuronal specificity of an acupoint: electroacupuncture stimulation of Yanglingquan (GB34) and its sham point","volume":"464","author":"Na","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2013.11.028_bib31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1468-1331.2009.02866.x","article-title":"Large differences in levodopa dose requirement in Parkinson's disease: men use higher doses than women","volume":"17","author":"Nyholm","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.brainres.2013.11.028_bib32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.nbd.2007.10.001","article-title":"l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation","volume":"29","author":"Picconi","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2013.11.028_bib33","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1212\/WNL.36.11.1528","article-title":"Low-dose l-dopa therapy in Parkinson's disease: a 6-year follow-up study","volume":"36","author":"Poewe","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2013.11.028_bib34","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0893-133X(99)00144-X","article-title":"Effects of SCH 58261, an adenosine A(2A) receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine-lesioned rats. Lack of tolerance after chronic caffeine intake","volume":"22","author":"Popoli","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2013.11.028_bib35","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJM200005183422004","article-title":"A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group","volume":"342","author":"Rascol","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2013.11.028_bib36","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1523\/JNEUROSCI.0852-07.2007","article-title":"Critical involvement of cAMP\/DARPP-32 and extracellular signal-regulated protein kinase signaling in l-DOPA-induced dyskinesia","volume":"27","author":"Santini","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2013.11.028_bib37","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/j.1742-4658.2008.06296.x","article-title":"Parkinson's disease: levodopa-induced dyskinesia and signal transduction","volume":"275","author":"Santini","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.brainres.2013.11.028_bib38","doi-asserted-by":"crossref","first-page":"12138","DOI":"10.1073\/pnas.96.21.12138","article-title":"Feeding behavior in dopamine-deficient mice","volume":"96","author":"Szczypka","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2013.11.028_bib39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1468-1331.2008.02106.x","article-title":"Relationship between weight, levodopa and dyskinesia: the significance of levodopa dose per kilogram body weight","volume":"15","author":"Sharma","year":"2008","journal-title":"Eur. J. Neurol."},{"issue":"Spec no. 2","key":"10.1016\/j.brainres.2013.11.028_bib40","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1093\/hmg\/ddm159","article-title":"Parkinson's disease","volume":"16","author":"Thomas","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.brainres.2013.11.028_bib41","first-page":"S49","article-title":"Parkinson's disease\u2014Part 2: treatment of motor symptoms","volume":"14","author":"Weintraub","year":"2008","journal-title":"Am. J. Manage. Care"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899313015242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899313015242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T06:24:15Z","timestamp":1538979855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899313015242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":41,"alternative-id":["S0006899313015242"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2013.11.028","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined treatment with acupuncture reduces effective dose and alleviates adverse effect of l-dopa by normalizing Parkinson's disease-induced neurochemical imbalance","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2013.11.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}